Please try another search
Jordan Kovler, the Chief Executive Officer of Greenidge Generation Holdings Inc. (NASDAQ:GREE), recently acquired 5,000 shares of the company's Class A Common Stock. The...
John C. Love, a director at InterGroup Corp (NASDAQ:INTG), recently sold 10,485 shares of the company's common stock. The transaction, which took place on December 20, 2024, was...
American Strategic Investment Co. (NYSE:NYC), currently trading at a significant discount to book value with a Price/Book ratio of 0.25, recently witnessed insider buying activity...
In a recent transaction, Mark Reinstra, Chief Legal Officer and Corporate Secretary of Roblox Corp (NYSE:RBLX), sold shares worth approximately $1.43 million. The sales...
AUSTIN, Texas—Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. (NASDAQ:NTRA), a company whose stock has delivered an impressive 154% return year-to-date...
John Fesko, the President and Chief Business Officer of Natera, Inc. (NASDAQ:NTRA), recently sold shares of the company's common stock, according to a regulatory filing submitted...
Roivant Sciences Ltd. (NASDAQ:ROIV), a biopharmaceutical company with a market capitalization of $8.7 billion and an "GREAT" financial health score according to InvestingPro, has...
Redmile Group, LLC, a prominent investment management firm, reported a significant transaction involving shares of Fate Therapeutics Inc. (NASDAQ:FATE), a biotech company currently...
Eric Venker, the President and Chief Operating Officer of Roivant Sciences Ltd. (NASDAQ:ROIV), an $8.7 billion market cap company currently trading near its 52-week high of $13.05,...
Kavita Patel, a director at Arcellx, Inc. (NASDAQ:ACLX), recently sold shares of the company in a transaction valued at approximately $115,450. The sale, which took place on...
Following this sale, Espinoza retains ownership of 20,647 shares of Ligand Pharmaceuticals (NASDAQ:LGND). The shares were sold in multiple transactions, with prices ranging...
Grid Dynamics Holdings, Inc. (NASDAQ:GDYN) CEO Leonard Livschitz recently sold a significant portion of his holdings in the company. According to a filing with the Securities and...
Dorchester Minerals Operating LP has recently increased its stake in Dorchester Minerals, L.P. (NASDAQ:DMLP), a $1.56 billion market cap company, by acquiring additional common...
Sheila Gujrathi, a director at Ventyx Biosciences, Inc. (NASDAQ:VTYX), recently purchased 130,000 shares of the company's common stock. The transaction, which took place on...
James Kevin Hanna, Senior Vice President, Controller & Chief Accounting Officer at Medical Properties Trust Inc . (NYSE:MPW), recently sold 11,641 shares of the company's...
BIRMINGHAM, AL—Hooper Rosa Handley, Senior Vice President of Operations at Medical Properties Trust Inc . (NYSE:MPW), recently sold 3,000 shares of the company's common...
Anurag Saha, the Chief Accounting Officer of CrowdStrike Holdings, Inc. (NASDAQ:CRWD), recently executed a series of stock sales totaling approximately $1.7 million, according to a...
On December 23, Michael Sentonas, President of CrowdStrike Holdings, Inc. (NASDAQ:CRWD), sold a total of 10,801 shares of the company's Class A common stock. The transactions,...
George Kurtz, President and CEO of CrowdStrike Holdings, Inc. (NASDAQ:CRWD), recently sold a significant portion of his holdings in the cybersecurity company. According to a filing...
Burt Podbere, the Chief Financial Officer of CrowdStrike Holdings, Inc. (NASDAQ:CRWD), recently sold shares of the company worth approximately $4 million. The transactions,...
SUNNYVALE, Calif.—Henry Shawn, the Chief Security Officer of CrowdStrike Holdings, Inc. (NASDAQ:CRWD), recently sold shares worth approximately $4.89 million, according to a...
Terrance McGuire, a director at Invivyd, Inc. (NASDAQ:IVVD), has reported a series of stock sales totaling $164,867, according to a recent SEC filing. The transactions occurred...
The purchase comes after a 1-for-7 reverse stock split by Surf Air Mobility, which took effect on August 19, 2024, and is reflected in the current number of shares Albert owns....
Christopher B. Paisley, a director at Ambarella Inc . (NASDAQ:AMBA), recently sold 1,500 ordinary shares of the company, according to a filing with the Securities and Exchange...
Sudhin Shahani, a director at Surf Air Mobility Inc. (NYSE:SRFM), has increased his holdings in the company by purchasing 17,237 shares of common stock. The transaction, which took...
In a recent transaction, Heng Jun Hong, a director at Luminar Technologies, Inc. (NASDAQ:LAZR), sold 72,842 shares of the company's Class A Common Stock. The shares were sold at...
Mark Andrew Wilson, the Chief Legal Officer at Nektar Therapeutics (NASDAQ:NKTR), recently sold shares of the company's common stock. According to a Form 4 filing with the...
Kirsten Spears, the Chief Financial Officer and Chief Accounting Officer of Broadcom Inc. (NASDAQ:AVGO), recently sold a significant portion of her holdings in the company....
This strategic move by Berkshire Hathaway (NYSE:BRKa) reflects continued confidence in Verisign (NASDAQ:VRSN)'s business model and growth potential. Verisign, headquartered in...
Diane M. Bryant, a director at Broadcom Inc. (NASDAQ:AVGO), recently sold a significant portion of her holdings in the semiconductor company. According to a filing with the...
The shares were sold at prices ranging from $1.23 to $1.37 per share, with a weighted average sale price of $1.2936 per share. Following these transactions, Vieceli retains...
Andrew Arno, a director at Oncocyte Corp (NASDAQ:OCX), recently acquired 12,500 shares of the company’s common stock at a weighted average price of $2.108 per share. This...
Javier Olivan, Chief Operating Officer at Meta Platforms, Inc. (NASDAQ:META), has sold 413 shares of the company's Class A common stock, according to a recent SEC filing. The sale...
Mark Zuckerberg, CEO of Meta Platforms, Inc. (NASDAQ:META), recently sold a substantial number of Class A Common Stock shares, according to a Form 4 filing with the Securities and...
Gregory M. Weinhoff, Chief Business Officer at Centessa Pharmaceuticals plc (NASDAQ:CNTA), a company that has seen its stock surge over 117% in the past year according to...